Equity Analysis /
United States of America

US : Amneal Pharmaceuticals Inc. - AMRX | Positive PIII On IPX-203 Though Will Incremental Efficacy Overcome Payer Resistance

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    26 August 2021
    Published by